H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Medicine D-index 73 Citations 17,536 326 World Ranking 13402 National Ranking 500

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Psychiatry
  • Major depressive disorder

His primary areas of study are Bipolar disorder, Psychiatry, Internal medicine, Depression and Mania. His research in Bipolar disorder intersects with topics in Intervention, Neurocognitive, Schizophrenia and Clinical psychology. He interconnects Disease and Placebo-controlled study in the investigation of issues within Psychiatry.

His biological study spans a wide range of topics, including Placebo and Endocrinology. His Depression research includes themes of Mental health, Oxidative stress, Physiology and Mood. The various areas that Seetal Dodd examines in his Mania study include Dopaminergic, Dopamine hypothesis of schizophrenia, Mood swing and Mental illness.

His most cited work include:

  • Pathways underlying neuroprogression in bipolar disorder : focus on inflammation, oxidative stress and neurotrophic factors (807 citations)
  • Pathways underlying neuroprogression in bipolar disorder : focus on inflammation, oxidative stress and neurotrophic factors (807 citations)
  • Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorder (289 citations)

What are the main themes of his work throughout his whole career to date?

Seetal Dodd mostly deals with Psychiatry, Bipolar disorder, Internal medicine, Depression and Clinical psychology. His research in Mood, Mental health, Anxiety, Schizoaffective disorder and Antidepressant are components of Psychiatry. His work in the fields of Bipolar disorder, such as Mania, intersects with other areas such as Clinical neurology.

While the research belongs to areas of Internal medicine, Seetal Dodd spends his time largely on the problem of Placebo, intersecting his research to questions surrounding Adjunctive treatment. His Depression research includes elements of Oxidative stress, Pharmacotherapy, Osteoporosis and Comorbidity. His studies in Clinical psychology integrate themes in fields like Prevalence of mental disorders and Bipolar I disorder.

He most often published in these fields:

  • Psychiatry (75.33%)
  • Bipolar disorder (81.88%)
  • Internal medicine (45.63%)

What were the highlights of his more recent work (between 2017-2021)?

  • Bipolar disorder (81.88%)
  • Internal medicine (45.63%)
  • Randomized controlled trial (15.72%)

In recent papers he was focusing on the following fields of study:

Seetal Dodd spends much of his time researching Bipolar disorder, Internal medicine, Randomized controlled trial, Clinical trial and Placebo. His study of Mania is a part of Bipolar disorder. The study incorporates disciplines such as Oncology, Placebo-controlled study and Depression in addition to Internal medicine.

His research integrates issues of Rating scale, Quality of life, Autism spectrum disorder, Major depressive disorder and Physical therapy in his study of Randomized controlled trial. His Clinical trial research incorporates elements of Varenicline, Smoking cessation, Acetylcysteine, Nutraceutical and Abstinence. Seetal Dodd has researched Placebo in several fields, including Aspirin, Adverse effect and Clinical endpoint.

Between 2017 and 2021, his most popular works were:

  • Post-Operative Cognitive Dysfunction: An exploration of the inflammatory hypothesis and novel therapies. (74 citations)
  • A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo (36 citations)
  • A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo (36 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Major depressive disorder
  • Psychiatry

Seetal Dodd focuses on Bipolar disorder, Randomized controlled trial, Major depressive disorder, Placebo and Bioinformatics. With his scientific publications, his incorporates both Bipolar disorder and Presentation. His Randomized controlled trial study integrates concerns from other disciplines, such as Mania, Physical therapy and Clinical trial.

His Major depressive disorder study incorporates themes from Rosuvastatin Calcium, Rosuvastatin, Mood disorders, Substance abuse and Aspirin. His work in Placebo addresses issues such as Internal medicine, which are connected to fields such as Rating scale, Clinical Global Impression and Young Mania Rating Scale. Seetal Dodd focuses mostly in the field of Bioinformatics, narrowing it down to topics relating to Schizophrenia and, in certain cases, Neuroprotection, Proinflammatory cytokine, Celecoxib, Autism spectrum disorder and Depression.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Pathways underlying neuroprogression in bipolar disorder : focus on inflammation, oxidative stress and neurotrophic factors

Michael Berk;Flavio P Kapczinski;Ana Cristina Andreazza;Ana Cristina Andreazza;Olivia Dean;Olivia Dean.
Neuroscience & Biobehavioral Reviews (2011)

1062 Citations

N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility

Seetal Dodd;Olivia Dean;David Leon Copolov;Gin S Malhi.
Expert Opinion on Biological Therapy (2008)

397 Citations

Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorder

M. Berk;M. Berk;S. Dodd;M. Kauer-Sant'Anna;G. S. Malhi.
Acta Psychiatrica Scandinavica (2007)

389 Citations

The validity of the 21-item version of the Depression Anxiety Stress Scales as a routine clinical outcome measure.

Felicity Ng;Thomas Trauer;Seetal Dodd;Tom Callaly.
Acta Neuropsychiatrica (2007)

271 Citations

Setting the Stage: From Prodrome to Treatment Resistance in Bipolar Disorder

Michael Berk;Michael Berk;Philippe Conus;Nellie Lucas;Karen Hallam.
Bipolar Disorders (2007)

254 Citations

Vitamin D deficiency may play a role in depression

Michael Berk;Kerrie M. Sanders;Julie A. Pasco;Felice N. Jacka.
Medical Hypotheses (2007)

235 Citations

Glutathione: a novel treatment target in psychiatry.

Michael Berk;Michael Berk;Felicity Ng;Olivia Dean;Seetal Dodd.
Trends in Pharmacological Sciences (2008)

227 Citations

History of illness prior to a diagnosis of bipolar disorder or schizoaffective disorder

M. Berk;S. Dodd;P. Callaly;L. Berk.
Journal of Affective Disorders (2007)

226 Citations

A review of vulnerability and risks for schizophrenia: Beyond the two hit hypothesis

Justin Davis;Harris Eyre;Felice N Jacka;Seetal Dodd;Seetal Dodd.
Neuroscience & Biobehavioral Reviews (2016)

224 Citations

Does stage of illness impact treatment response in bipolar disorder? Empirical treatment data and their implication for the staging model and early intervention.

Michael Berk;Alan Brnabic;Seetal Dodd;Seetal Dodd;Katarina Kelin.
Bipolar Disorders (2011)

217 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Seetal Dodd

Michael Berk

Michael Berk

Deakin University

Publications: 498

Gin S Malhi

Gin S Malhi

University of Sydney

Publications: 148

Flávio Kapczinski

Flávio Kapczinski

McMaster University

Publications: 134

Michael Maes

Michael Maes

Chulalongkorn University

Publications: 131

Eduard Vieta

Eduard Vieta

University of Barcelona

Publications: 128

André F. Carvalho

André F. Carvalho

Centre for Addiction and Mental Health

Publications: 114

Roger S. McIntyre

Roger S. McIntyre

University Health Network

Publications: 101

Julie A. Pasco

Julie A. Pasco

Deakin University

Publications: 89

João Quevedo

João Quevedo

The University of Texas Health Science Center at Houston

Publications: 69

Felice N. Jacka

Felice N. Jacka

Deakin University

Publications: 57

Patrick D. McGorry

Patrick D. McGorry

University of Melbourne

Publications: 54

Jan Scott

Jan Scott

Newcastle University

Publications: 49

Lars Vedel Kessing

Lars Vedel Kessing

University of Copenhagen

Publications: 47

Lakshmi N. Yatham

Lakshmi N. Yatham

University of British Columbia

Publications: 46

Marion Leboyer

Marion Leboyer

Université Paris Cité

Publications: 45

Allan H. Young

Allan H. Young

South London and Maudsley NHS Foundation Trust

Publications: 45

Something went wrong. Please try again later.